Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
USP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMCR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAFD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KDM7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYT15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPRIPL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CH25H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on